F. Asarcikli Et Al. , "Larotrectinib in NTRK Fusion-Positive Locally Advanced or Metastatic Soft Tissue Sarcomas in Children: A Case Series," PEDIATRIC BLOOD & CANCER , vol.68, 2021
Asarcikli, F. Et Al. 2021. Larotrectinib in NTRK Fusion-Positive Locally Advanced or Metastatic Soft Tissue Sarcomas in Children: A Case Series. PEDIATRIC BLOOD & CANCER , vol.68 .
Asarcikli, F., Kebudi, R., Sozmen, B. O., Erbey, F., & Buyukkapu, S. B., (2021). Larotrectinib in NTRK Fusion-Positive Locally Advanced or Metastatic Soft Tissue Sarcomas in Children: A Case Series. PEDIATRIC BLOOD & CANCER , vol.68.
Asarcikli, F. Et Al. "Larotrectinib in NTRK Fusion-Positive Locally Advanced or Metastatic Soft Tissue Sarcomas in Children: A Case Series," PEDIATRIC BLOOD & CANCER , vol.68, 2021
Asarcikli, F. Et Al. "Larotrectinib in NTRK Fusion-Positive Locally Advanced or Metastatic Soft Tissue Sarcomas in Children: A Case Series." PEDIATRIC BLOOD & CANCER , vol.68, 2021
Asarcikli, F. Et Al. (2021) . "Larotrectinib in NTRK Fusion-Positive Locally Advanced or Metastatic Soft Tissue Sarcomas in Children: A Case Series." PEDIATRIC BLOOD & CANCER , vol.68.
@article{article, author={F. Asarcikli Et Al. }, title={Larotrectinib in NTRK Fusion-Positive Locally Advanced or Metastatic Soft Tissue Sarcomas in Children: A Case Series}, journal={PEDIATRIC BLOOD & CANCER}, year=2021}